Inato blog

post

Webinar Recap: Unlocking Site Potential - Engaging Diverse Populations and Leveraging Technology

Inato hosted a panel discussion in partnership with Marcus Evans, Sanofi and The Center for Cancer Prevention and Treatment.
post

The Marketplace Diversity Assessment: Improving Diversity in Clinical Trials

The evidence-based diversity assessment allows sponsors to easily match their protocols to sites in the Inato Marketplace with expertise in diversity. Sites complete a 14-point assessment which evaluates three facets of diversity: community, research team, recruitment and outreach approach.
post

3 Steps to Secure More Clinical Trials at Your Site in the Next 12 Months

On Thursday June 18th between 12:00 - 1:00 pm EST, Inato hosted a discussion on how to secure more clinical trials for your site
post

Growing From A Feasibility Platform To A Clinical Trials Marketplace

Inato's strategic transition from a feasibility platform to offering a two-sided marketplace that matches clinical research sites to the sponsor trials best suited for them
post

Cutting Through the Chaos to Navigate Corona Virus Disease Clinical Trials

Doctors grappling with fragmented data sources on COVID-19 trials can use Inato's Anticovid Platform to search trials, analyze trends, and act effectively
post

Interview with Christophe Massard, MD PhD

Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of ESMO, ASCO and AACR and has participated in over 130 trials in the past five years. His research focuses on early clinical trials, precision medicine, GU cancers (prostate, bladder and testis) and glioblastoma.